DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20162137

Obstetric and neonatal outcome in pregnancies complicated by hemolysis elevated liver enzymes low platelet count syndrome at a tertiary care centre in India

Nidhi O. Bang, Meena N. Satia, Supriya Poonia

Abstract


Background: The hemolysis elevated liver enzymes low platelet count (HELLP) syndrome is a serious complication in pregnancy characterized by hemolysis, elevated liver enzymes and low platelet count occurring in 0.4 to 0.7% of all pregnancies and in 10-12% of cases with severe preeclampsia. This present study will throw some light on occurrence, diagnosis, complications, treatment, mode of delivery and the neonatal outcome.

Methods: A prospective observational study was conducted in the department of Obstetrics and Gynecology at Seth G.S. Medical College and KEM hospital which is a tertiary care centre in Mumbai in the state of Maharashtra India from September 2013 to December 2014 after the approval of institutional ethics committee. The inclusion criteria were only those patients in whom HELLP syndrome was diagnosed on the basis of blood investigations, laboratory parameters and clinical picture. All those patients who did not fulfill the diagnostic criteria for HELLP syndrome were excluded.

Results: In our study, according to the Mississippi classification, 15% belonged to class 1, 62% to class 2 and 23% to class 3. The peak age of incidence was 21-30 years (78%) and majority were primigravida (57%). Majority (91%) presented with headache and the other associated complains were epigastric pain, nausea, vomiting and blurring of vision. Only 32% patients presented at term (>37 weeks), 65% patients were at 28-36 weeks of gestation and 3% had very early onset HELLP syndrome. Majority (65%) had severe hypertension (BP>160/110 mm of Hg) with albuminuria of grade +3 to +4. Majority (83%) of the patients were given injection MgSO4 either for prophylaxis or treatment of eclampsia. 65% patients delivered vaginally. 70% were live births, out of which 8% died in the early neonatal period. Severe maternal complications such as eclampsia, hematuria, acute kidney injury, abruption placentae, severe anemia and DIC were seen in 63% patients. 57% of patients were transfused with blood and blood products and 7% required intensive care management.

Conclusions: A multidisciplinary approach is of utmost importance along with early diagnosis and prompt treatment to prevent the cataclysmic deterioration of patients with HELLP syndrome.

Keywords


HELLP syndrome, Pre-eclampsia, Hemolysis

Full Text:

PDF

References


Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count; a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159-67.

Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome: Subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol. 1995;172:125-9.

Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with HELLP syndrome. Am J Obstet Gynecol. 1993;169(4):1000-6.

Geary M. The HELLP syndrome. Br J Obstet Gynecol. 1997;104:887-91.

Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BG, Regan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes and low platelets in sever preeclampsia-eclampsia. Am J Obstet Gynecol. 1986;155(3):501-8.

Sibai BM. The HELLP syndrome much ado about nothing? Am J Obstet Gynecol. 1990;162:311-6.

Sibai BM, Ramadan MK. Acute renal failure in pregnancies complicated by HELLP syndrome. Am J Obstet Gynecol. 1993;168:1682-90.

Vigil P, Gracia D. Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome. International Journal of Gynecology and Obstetrics. 2001;72:17-23.

Javier E, Fonseca M, Clandia C. Dexamethasone treatment does not improve the outcome of woman with HELLP syndrome: a double blind, placebo controlled randomized clinical trail. Am J Obstet Gynecol. 2005;193:1591-8.

Isler CM, Rinehart BIL, Terrone DA. Maternal mortality associated with HELLP hemolysis, elevated liver and low platelets syndrome. Am J Obstet Gynecol. 1999;181:924-8.

Martin JN, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia, comparative analysis of HELLP hemolysis, elevated liver enzymes levels and low platelet count syndrome classification. Am J Obstet Gynecol. 1999;180(6):1373-82.

Banoo S, Makhdoomi TA, Mir S, Malik J. Incidence of HELLP syndrome in sever pregnancy induced hypertension and its impact on maternal and fetal outcome. JK Practitioner. 2007;14(2):92-4.

Kim HY, Sohn YS, Lim JH, Kim EH, Kwon JW, Park YW, et al. Neonatal outcome after preterm delivery in HELLP syndrome. Yonsei Medical Journal. 2006;47(3):393-8.

Imir GA, Iclal Ozdemir KOL, Kaygusuz K, Cetin A, Cetin M, Gonullu TGM. Perinatal outcomes in HELLP syndrome. J Turkish-German Gynecol Associ. 2008;9(2):89-93.